NFAT regulates calcium-sensing receptor-mediated TNF production

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 5, 2006, Pages

  Abdullah, Huda Ismail ^a   Pedraza, Paulina L ^a   Hao, Shoujin ^a   Rodland, Karin D ^b   McGiff, John C ^a   Ferreri, Nicholas R ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

Calcium sensing receptor; Cyclosporine A; Loop of Henle; Tumor necrosis factor

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CALCINEURIN; CALCINEURIN INHIBITOR; CALCIUM SENSING RECEPTOR; CYCLOSPORIN A; FIREFLY LUCIFERASE; PEPTIDE VIVIT; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; EXTRACELLULAR CALCIUM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; KIDNEY CELL; KIDNEY MEDULLA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

EID: 33646595971     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00223.2005     Document Type: Article

References (68)

1. Aramburu J, Heitman J, and Crabtree GR. Calcineurin: a central controller of signalling in eukaryotes. EMBO J 5: 343-348, 2004.
2. Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, and Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285: 2129-2133, 1999.
3. Awata H, Huang C, Handlogten ME, and Miller RT. Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J Biol Chem 276: 34871-34879, 2001.
4. 2+-sensing receptor from bovine parathyroid. Nature 366: 575-580, 1993.
5. Brown EM and MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81: 239-297, 2001.
6. Brown EM, Vassilev PM, and Hebert SC. Calcium ions as extracellular messengers. Cell 83: 679-682, 1995.
7. Carroll MA, McGiff JC, and Ferreri NR. Products of arachidonic acid metabolism. Methods Mol Med 86: 385-397, 2003.
8. Catella Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, Lasseter KC, Quan H, Gertz BJ, and FitzGerald GA. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 289: 735-741, 1999.
9. Crabtree GR. Calcium, calcineurin, and the control of transcription. J Biol Chem 276: 2313-2316, 2001.
10. Dahl SC, Handler JS, and Kwon HM. Hypertonicity-induced phosphorylation and nuclear localization of the transcription factor TonEBP. Am J Physiol Cell Physiol 280: C248-C253, 2001.
11. Dignam JD, Lebovitz RM, and Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489, 1983.
12. DiPetrillo K, Coutermarsh B, Soucy N, Hwa J, and Gesek F. Tumor necrosis factor induces sodium retention in diabetic rats through sequential effects on distal tubule cells. Kidney Int 65: 1676-1683, 2004.
13. El-Hajj Fuleihan G, Seifter J, Scott J, and Brown EM. Calcium-regulated renal calcium handling in healthy men: relationship to sodium handling. J Clin Endocrinol Metab 83: 2366-2372, 1998.
14. Escalante BA, Ferreri NR, Dunn CE, and McGiff JC. Cytokines affect ion transport in primary cultured thick ascending limb of Henle's loop cells. Am J Physiol Cell Physiol 266: C1568-C1576, 1994.
15. Ferraris JD, Williams CK, Persaud P, Zhang Z, Chen Y, and Burg MB. Activity of the TonEBP/OREBP transactivation domain varies directly with extracellular NaCl concentration. Proc Natl Acad Sci USA 99: 739-744, 2002.
16. Ferreri NR, An SJ, and McGiff JC. Cyclooxygenase-2 expression and function in the medullary thick ascending limb. Am J Physiol Renal Physiol 277: F360-F368, 1999.
17. Ferreri NR, Escalante BA, Zhao Y, An S, and McGiff JC. Angiotensin II induces TNF production by the thick ascending limb: functional implications. Am J Physiol Renal Physiol 274: F148-F155, 1998.
18. Ferreri NR, Zhao Y, Takizawa H, and McGiff JC. Tumor necrosis factor-α/angiotensin interactions and regulation of blood pressure. J Hypertens 15: 1481-1484, 1997.
19. Friedman PA and Gesek FA. Cellular calcium transport in renal epithelia: measurement, mechanisms, and regulation. Physiol Rev 75: 429-471, 1995.
20. Godwin SL and Soltoff SP. Extracellular calcium and platelet-derived growth factor promote receptor-mediated chemotaxis in osteoblasts through different signaling pathways. J Biol Chem 272: 11307-11312, 1997.
21. Goldfeld AE, McCaffrey PG, Strominger JL, and Rao A. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor-α gene promoter. J Exp Med 178: 1365-1379, 1993.
22. Goldfeld AE, Tsai E, Kincaid R, Belshaw PJ, Schrieber SL, Strominger JL, and Rao A. Calcineurin mediates human tumor necrosis factor-α gene induction in stimulated T and B cells. J Exp Med 180: 763-768, 1994.
23. Guo G, Morrissey J, McCracken R, Tolley T, Liapis H, and Klahr S. Contributions of angiotensin II and tumor necrosis factor-α to the development of renal fibrosis. Am J Physiol Renal Physiol 280: F777-F785, 2001.
24. Hebert SC. Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int 50: 2129-2139, 1996.
25. Hobson SA, Wright J, Lee F, McNeil SE, Bilderback T, and Rodland KD. Activation of the MAP kinase cascade by exogenous calcium-sensing receptor. Mol Cell Endocrinol 200: 189-198, 2003.
26. Hocherl K, Kees F, Kramer BK, and Kurtz A. Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression. Kidney Int 65: 2071-2080, 2004.
27. Hofer AM and Brown EM. Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 4: 530-538, 2003.
28. Johns DG and Webb RC. TNF-α-induced endothelium-independent vasodilation: a role for phospholipase A2-dependent ceramide signaling. Am J Physiol Heart Circ Physiol 275: H1592-H1598, 1998.
29. 2 inhibits Na-K-2Cl cotransport in medullary thick ascending limb cells. Am J Physiol Cell Physiol 271: C354-C361, 1996.
30. Kalantarinia K, Awad AS, and Siragy HM. Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats. Kidney Int 64: 1208-1213, 2003.
31. Kaskel FJ, Devarajan P, Arbeit LA, Partin JS, and Moore LC. Cyclosporine nephrotoxicity: sodium excretion, autoregulation, and angiotensin II. Am J Physiol Renal Fluid Electrolyte Physiol 252: F733-F742, 1987.
32. Kifor O, MacLeod RJ, Diaz R, Bai M, Yamaguchi T, Yao T, Kifor I, and Brown EM. Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 280: F291-F302, 2001.
33. Kos CH, Karaplis AC, Peng JB, Hediger MA, Goltzman D, Mohammad KS, Guise TA, and Pollak MR. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest 111: 1021-1028, 2003.
34. + channel in the thick ascending limb of the rat kidney. Am J Physiol Cell Physiol 278: C905-C913, 2000.
35. Lopez-Rodriguez C, Aramburu J, Jin L, Rakeman AS, Michino M, and Rao A. Bridging the NFAT and NF-κB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity 15: 47-58, 2001.
36. Lopez-Rodriguez C, Aramburu J, Rakeman AS, and Rao A. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc Natl Acad Sci USA 96: 7214-7219, 1999.
37. Macian F, Lopez-Rodriguez C, and Rao A. Partners in transcription: NFAT and AP-1. Oncogene 20: 2476-2489, 2001.
38. Macica C, Escalante BA, Conners MS, and Ferreri NR. TNF production by the medullary thick ascending limb of Henle's loop. Kidney Int 46: 113-121, 1994.
39. McNeil SE, Hobson SA, Nipper V, and Rodland KD. Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium. J Biol Chem 273: 1114-1120, 1998.
40. Miyakawa H, Woo SK, Dahl SC, Handler JS, and Kwon HM. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc Natl Acad Sci USA 96: 2538-2542, 1999.
41. Pazianas M, Adebanjo OA, Shankar VS, James SY, Colston KW, Maxwell JD, and Zaidi M. Extracellular cation sensing by the enterocyte: prediction of a novel divalent cation "receptor". Biochem Biophys Res Commun 210: 948-953, 1995.
42. Rao A, Luo C, and Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15: 707-747, 1997.
43. 2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol Renal Physiol 274: F611-F622, 1998.
44. 2+ sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 271: F951-F956, 1996.
45. Riccardi D, Park J, Lee W, Gamba G, Brown EM, and Hebert SC. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation/sensing receptor. Proc Natl Acad Sci USA 92: 131-135, 1995.
46. Rodriguez F, Llinas MT, Gonzalez JD, Rivera J, and Salazar FJ. Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake. Hypertension 36: 276-281, 2000.
47. Rossat J, Maillard M, Nussberger J, Brunner HR, and Burnier M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 66: 76-84, 1999.
48. Ruat M, Molliver ME, Snowman AM, and Snyder SH. Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. Proc Natl Acad Sci USA 92: 3161-3165, 1995.
49. Schwartz JI, Vandormael K, Malice MP, Kalyani RN, Lasseter KC, Holmes GB, Gertz BJ, Gottesdiener KM, Laurenzi M, Redfern KJ, and Brune K. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther 72: 50-61, 2002.
50. Siegl H and Ryffel B. Effect of cyclosporin on renin-angiotensin- aldosterone system. Lancet 2: 1274, 1982.
51. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, and Geis GS. Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study. JAMA 284: 1247-1255, 2000.
52. Siragy HM, Awad A, Abadir P, and Webb R. The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-α in diabetic rats. Endocrinology 144: 2229-2233, 2003.
53. 2 on chloride transport across the rabbit thick ascending limb of Henle. J Clin Invest 64: 495-502, 1979.
54. Tian W, Salanova M, Xu H, Lindsley JN, Oyama TT, Anderson S, Bachmann S, and Cohen DM. Renal expression of osmotically responsive cation channel TRPV4 is restricted to water-impermeant nephron segments. Am J Physiol Renal Physiol 287: F17-F24, 2004.
55. 2+ signals and immunosuppression. Nature 383: 837-840, 1996.
56. Todorov V, Muller M, Schweda F, and Kurtz A. Tumor necrosis factor-α inhibits renin gene expression. Am J Physiol Regul Integr Comp Physiol 283: R1046-R1051, 2002.
57. Trama J, Lu Q, Hawley RG, and Ho SN. The NFAT-related protein NFATL1 (TonEBP/NFAT5) is induced upon T cell activation in a calcineurin-dependent manner. J Immunol 165: 4884-4894, 2000.
58. Tu Q, Pi M, Karsenty G, Simpson L, Liu S, and Quarles LD. Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. J Clin Invest 111: 1029-1037, 2003.
59. 2 in vitro on mTAL Na-K-ATPase of the rat kidney. Pflügers Arch 415: 648-650, 1990.
60. Wang D, An SJ, Wang WH, McGiff JC, and Ferreri NR. CaR-mediated COX-2 expression in primary cultured mTAL cells. Am J Physiol Renal Physiol 281: F658-F664, 2001.
61. Wang D, McGiff JC, and Ferreri NR. Regulation of cyclooxygenase isoforms in the renal thick ascending limb: effects of extracellular calcium. J Physiol Pharmacol 51: 587-595, 2000.
62. Wang D, Pedraza PL, Abdullah HI, McGiff JC, and Ferreri NR. Calcium-sensing receptor-mediated TNF production in medullary thick ascending limb cells. Am J Physiol Renal Physiol 283: F963-F970, 2002.
63. + channels in rat TAL. Am J Physiol Renal Physiol 273: F421-F429, 1997.
64. 2+ increase and arachidonic acid release in FRTL-5 thyroid cells. Biochim Biophys Acta 1223: 101-106, 1994.
65. Ward DT and Riccardi D. Renal physiology of the extracellular calcium-sensing receptor. Pflügers Arch 445: 169-176, 2002.
66. + channels in the thick ascending limb of rat kidney. Am J Physiol Renal Physiol 285: F491-F497, 2003.
67. 2+-sensing receptor mRNAs along the rat nephron. Am J Physiol Renal Fluid Electrolyte Physiol 272: F751-F758, 1997.
68. Yang T, Singh I, Pham H, Sun D, Smart A, Schnermann JB, and Briggs JP. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol Renal Physiol 274: F481-F489, 1998.